Brief: Nanogroup Unit Gets Positive Results Of Ex-Vivo Studies On Drug Candidate For Ovary Cancer
24/03/2022 07:24
March 24 (Reuters) - Nanogroup SA NNG.WA :
* UNIT NANOVELOS GETS POSITIVE RESULTS OF EX-VIVO STUDIES ON
DRUG
CANDIDATE TREATING OVARY CANCER
* SAID RESULTS ALLOW CHAMPIONS ONCOLOGY TO TEST
EFFECTIVENESS OF
DRUG CANDIDATE POL-EPI IN TREATING MICE WITH INJECTED OVARY
CANCER
Source text for Eikon: ID:nEM6ZvkLNa
Further company coverage: NNG.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))